Osteosarcoma Treatments
Find Osteosarcoma Treatments
Dactinomycin
View Brand InformationWhat is Dactinomycin?
Approved To Treat
Related Clinical Trials
Summary: Pediatric soft tissue sarcomas (STS) are a group of malignant tumors originating from primitive mesenchymal tissues and account for approximately 7% of childhood cancers. STS are broadly classified into rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS). RMS accounts for approximately one half of pediatric STS. As reported, PAX fusion-positive RMS is more aggressive than f...
Summary: This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate the use of evolutionary principles that apply to species and population dynamics as related to adaptation and extinction to populations of cancer cells that similarly adapt and that we are attempting to...
Summary: This phase III trial compares higher dose chemotherapy, with vincristine, dactinomycin and cyclophosphamide, over a shorter amount of time to lower dose chemotherapy plus maintenance, with vincristine, dactinomycin, cyclophosphamide, irinotecan and vinorelbine, over a longer amount of time, along with standard of care surgery and radiation, in patients with newly diagnosed intermediate risk rhabdo...
Related Latest Advances
Brand Information
- Secondary Malignancy and Leukemia
- Veno-occlusive Disease
- Extravasation
- Myelosuppression
- Immunizations
- Severe Mucocutaneous Reactions
- Renal Toxicity
- Hepatotoxicity
- Potentiation of Radiation Toxicity and Radiation Recall



